Suboxone 8 mg /2mg buprenorphine belongs to a group of medications known as partial opiate agonists.
Naloxone also belongs to a group of medications known as opiate antagonists.
N8 LOGO (Suboxone 8 mg / 2 mg)
Generic Name: buprenorphine/naloxone
Pill with imprint N8 LOGO is Orange, Six-sided and has been identified as Suboxone 8 mg / 2 mg. It is supplied by Reckitt Benckiser Pharmaceuticals, Inc..
The combination medication is used, together with an overall addiction treatment program that includes medical, social, and also psychological support, to treat adults who are dependent on opiates (narcotics) such as oxycodone or morphine. first of all a person addicted to narcotics who suddenly stops taking the narcotic may experience severe withdrawal symptoms.
. Marketing authorisation holder
Indivior UK Limited United Kingdom
Therapeutic indications
Substitution treatment for opioid drug dependence, within a framework of medical, social and also psychological treatment. The intention of the naloxone component is to deter intravenous misuse. Treatment is intended for use in adults and also adolescents over 15 years of age who have agreed to be treated for addiction.
Important Dosage and Administration Information
SUBOXONE sublingual film is administered sublingually or buccally as a single daily dose.
Medication should be prescribed in consideration of the frequency of visits. Provision of multiple refills is not advised early in treatment or without appropriate patient follow‐up visits.
Induction
Prior to induction, consideration should be given to the type of opioid dependence (i.e., long‐ or short‐acting opioid products), the time since last opioid use, and the degree or level of opioid dependence.
Reviews
There are no reviews yet.